Source: PR Newswire

Press Release: Sojournix : Sojournix To Present At Cowen And Company 39th Annual Health Care Conference

WALTHAM, Mass., March 5, 2019 /PRNewswire/ -- Sojournix, a clinical stage biopharmaceutical company dedicated to developing and commercializing transformative new medicines for the treatment of women's health and neuroendocrine disorders, today announced that Daniel Grau, President and...

Read full article »
Est. Annual Revenue
$100K-5.0M
Est. Employees
1-25
CEO Avatar

Co-Founder & CEO

Daniel Grau

CEO Approval Rating

84/100

Read more